1. Home
  2. SUNS vs ANTX Comparison

SUNS vs ANTX Comparison

Compare SUNS & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$8.14

Market Cap

126.3M

Sector

Real Estate

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.96

Market Cap

135.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
ANTX
Founded
2023
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
135.4M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SUNS
ANTX
Price
$8.14
$3.96
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
$8.75
$2.00
AVG Volume (30 Days)
77.8K
3.3M
Earning Date
03-12-2026
03-17-2026
Dividend Yield
14.72%
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$110.86
N/A
Revenue Next Year
$9.41
N/A
P/E Ratio
$8.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.80
$1.00
52 Week High
$11.78
$6.91

Technical Indicators

Market Signals
Indicator
SUNS
ANTX
Relative Strength Index (RSI) 26.55 60.80
Support Level N/A $1.05
Resistance Level $9.69 $6.91
Average True Range (ATR) 0.29 0.90
MACD -0.12 0.03
Stochastic Oscillator 7.39 49.70

Price Performance

Historical Comparison
SUNS
ANTX

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: